Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Proliferative Diabetic Retinopathy (PDR), (NPDR)- Pipeline Review, H2 2015

Thursday, November 17, 2016 3:51
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Download free PDF sample copy of Proliferative Diabetic Retinopathy (PDR) - http://www.researchbeam.com/proliferative-diabetic-retinopathy-pdr-global-clinical-trials-review-h1-2016-market/request-sample

Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2016 provides an overview of Proliferative Diabetic Retinopathy (PDR) clinical trials scenario. This report provides top line data relating to the clinical trials on Proliferative Diabetic Retinopathy (PDR). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).  Clinical Trial Reports are generated using proprietary database – Pharma track Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Get similar reports for your choice:

Global Diabetic Retinopathy Industry 2015 Market Research Report >>>> http://www.researchbeam.com/global-diabetic-retinopathy-industry-2015-research-report-market/request-sample

 

Diabetic Retinopathy – Pipeline Review, H1 2016 – http://www.researchbeam.com/diabetic-retinopathy-pipeline-review-h1-2016-market/request-sample

 

Non-Proliferative Diabetic Retinopathy (NPDR) Global Clinical Trials Review, H1, 2016 >>>> http://www.researchbeam.com/non-proliferative-diabetic-retinopathy-npdr-global-clinical-trials-review-h1-2016-market/request-sample 

 

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

 

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Reasons to buy

 

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

 

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease..

Table of content:

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Proliferative Diabetic Retinopathy (PDR) to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Proliferative Diabetic Retinopathy (PDR) to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Proliferative Diabetic Retinopathy (PDR) Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Proliferative Diabetic Retinopathy (PDR) 30
May 08, 2016: Acucela Initiates Phase 2 Clinical Trial Addressing Proliferative Diabetic Retinopathy 30
Clinical Trial Profile Snapshots 31
Appendix 88
Abbreviations 88
Definitions 88
Research Methodology 89
Secondary Research 89
About GlobalData 90
Contact Us 90
Disclaimer 90
Source 91

List Of Tables
List of Tables
Proliferative Diabetic Retinopathy (PDR) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Proliferative Diabetic Retinopathy (PDR) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Proliferative Diabetic Retinopathy (PDR) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Proliferative Diabetic Retinopathy (PDR) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Proliferative Diabetic Retinopathy (PDR) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Proliferative Diabetic Retinopathy (PDR) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Proliferative Diabetic Retinopathy (PDR) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proliferative Diabetic Retinopathy (PDR) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Proliferative Diabetic Retinopathy (PDR) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14
Proliferative Diabetic Retinopathy (PDR) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Proliferative Diabetic Retinopathy (PDR) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Proliferative Diabetic Retinopathy (PDR) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17
Proliferative Diabetic Retinopathy (PDR) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Proliferative Diabetic Retinopathy (PDR) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Proliferative Diabetic Retinopathy (PDR) Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Proliferative Diabetic Retinopathy (PDR) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Proliferative Diabetic Retinopathy (PDR) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Proliferative Diabetic Retinopathy (PDR) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Proliferative Diabetic Retinopathy (PDR) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

About Us:

We have business relations with numerous clients of different verticals. Hence, we bring to you market research reports of various fields and carter to number of organizations. This is the spot on place for all your market research needs. We are home to a very proactive and energetic team who strives to solve user queries as soon as possible. They will also help you to know about latest market trends and practices. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation. Visit more – http://www.researchbeam.com    

   

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.